SEC Form 4 · accession 0001209191-17-033575
PULSE BIOSCIENCES, INC. · PLSE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Brian B Dow
Officer — CFO & SVP Admin. and Finance
Period of report
May 16, 2017
Accepted (ET)
May 18, 2017 · 4:09 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001625101
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $27.14 | May 16, 2017 | A | 95,000 | A | Mar 15, 2017 | May 16, 2027 | Common Stock | 95,000 | 95,000 | D |
Explanation of responses
- F1The shares subject to the option will vest in equal monthly installments over a four year period that began on February 15, 2017, subject to the Reporting Person's continued service through each vesting date.